We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+10.09%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$6.26B
AUM Growth
+$363M
Cap. Flow
-$130M
Cap. Flow %
-2.08%
Top 10 Hldgs %
19.16%
Holding
2,624
New
54
Increased
718
Reduced
1,361
Closed
88

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Financials 14.02%
3 Healthcare 13.38%
4 Consumer Discretionary 9.94%
5 Industrials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XENT
1776
DELISTED
Intersect ENT, Inc
XENT
$244K ﹤0.01%
9,809
MODV
1777
DELISTED
ModivCare
MODV
$244K ﹤0.01%
4,125
PLUG icon
1778
Plug Power
PLUG
$3.21B
$244K ﹤0.01%
77,184
+23,844
+45% +$72.5K
AKBA icon
1779
Akebia Therapeutics
AKBA
$241M
$244K ﹤0.01%
38,571
+8,808
+30% +$41.9K
MDGL icon
1780
Madrigal Pharmaceuticals
MDGL
$11.7B
$243K ﹤0.01%
2,668
ATRA icon
1781
Atara Biotherapeutics
ATRA
$76.7M
$242K ﹤0.01%
588
-38
-6% -$13.1K
RCKT icon
1782
Rocket Pharmaceuticals
RCKT
$367M
$242K ﹤0.01%
10,616
OBK icon
1783
Origin Bancorp
OBK
$1.69B
$242K ﹤0.01%
6,385
-379
-6% -$13.3K
LBAI
1784
DELISTED
Lakeland Bancorp Inc
LBAI
$242K ﹤0.01%
13,896
-4,936
-26% -$81.3K
ON icon
1785
ON Semiconductor
ON
$31.8B
$241K ﹤0.01%
9,891
+33
+0.3% +$697
LYFT icon
1786
Lyft
LYFT
$6.48B
$241K ﹤0.01%
5,602
+4,617
+469% +$202K
CNST
1787
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$240K ﹤0.01%
+5,103
New +$147K
GCO icon
1788
Genesco
GCO
$394M
$240K ﹤0.01%
4,998
-382
-7% -$15.8K
SNEX icon
1789
StoneX
SNEX
$8.05B
$239K ﹤0.01%
24,827
DHT icon
1790
DHT Holdings
DHT
$3.09B
$239K ﹤0.01%
28,833
+6,794
+31% +$50.4K
UEIC icon
1791
Universal Electronics
UEIC
$66.6M
$238K ﹤0.01%
4,561
MNDT
1792
DELISTED
Mandiant, Inc. Common Stock
MNDT
$238K ﹤0.01%
14,412
-268
-2% -$4.3K
PACB icon
1793
Pacific Biosciences
PACB
$357M
$238K ﹤0.01%
46,264
+7,310
+19% +$37.2K
DOX icon
1794
Amdocs
DOX
$6.23B
$237K ﹤0.01%
3,286
+11
+0.3% +$749
KELYA icon
1795
Kelly Services Class A
KELYA
$566M
$237K ﹤0.01%
10,494
-599
-5% -$13.5K
IMGN
1796
DELISTED
Immunogen Inc
IMGN
$237K ﹤0.01%
46,351
-2,348
-5% -$7.97K
APTS
1797
DELISTED
Preferred Apartment Communities, Inc.
APTS
$237K ﹤0.01%
17,764
+723
+4% +$9.98K
VST icon
1798
Vistra
VST
$49.1B
$236K ﹤0.01%
10,278
+34
+0.3% +$877
NVST icon
1799
Envista
NVST
$4.51B
$236K ﹤0.01%
+7,955
New +$226K
NEWR
1800
DELISTED
New Relic, Inc.
NEWR
$236K ﹤0.01%
3,587
-67
-2% -$4.35K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2019 Portfolio in Review

As of Q4 2019, Metropolitan Life Insurance Company (MetLife) held 2,624 positions worth $6.26B, up 6.2% from $5.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2019 filing shows 54 new, 718 increased, 1,361 reduced and 88 closed positions. Its largest new stake was SolarEdge: 12,469 shares worth $1.19M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2019 buy was SolarEdge: 12,469 shares worth $1.19M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $35.2M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2019 reduction was Apple, cutting an estimated $8.1M.
  • Metropolitan Life Insurance Company (MetLife) fully exited iShares 20+ Year Treasury Bond ETF in Q4 2019, selling an estimated $143M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 19% of its $6.26B portfolio in Q4 2019.
  • Metropolitan Life Insurance Company (MetLife) opened 54 new positions and closed 88 in Q4 2019.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.2% quarter-over-quarter to $6.26B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2019, filed 14 Feb 2020.